BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 3536231)

  • 1. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN; Lai FM; Ho CP; Chan KW
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
    Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
    Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA nephropathy (IgAN) presenting with the nephrotic syndrome.
    Oviasu E
    Trop Geogr Med; 1992 Oct; 44(4):365-8. PubMed ID: 1295149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy.
    Mustonen J; Pasternack A; Rantala I
    Clin Nephrol; 1983 Oct; 20(4):172-6. PubMed ID: 6641024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
    García Camín RM; Cabezas A; Calero F; Ballarín JA
    Nefrologia; 2004; 24 Suppl 3():68-71. PubMed ID: 15219073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy.
    Han SH; Kang EW; Park JK; Kie JH; Han DS; Kang SW
    Nephrol Dial Transplant; 2011 May; 26(5):1570-5. PubMed ID: 20841490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y; Okada H; Saruta T; Suzuki H
    Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
    Chábová V; Tesar V; Zabka J; Rychlík I; Merta M; Jirsa M; Stejskalová A; Stejskal J
    Cas Lek Cesk; 1996 Dec; 135(24):803-6. PubMed ID: 9072300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party.
    Cameron JS; Healy MJ; Adu D
    Q J Med; 1990 Feb; 74(274):133-56. PubMed ID: 2189149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Grassi C; Limido D; Pasquali S; Passerini P; Volpini T; Locatelli F
    Proc Eur Dial Transplant Assoc; 1983; 19():717-23. PubMed ID: 6348763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular tip lesion in the 1962-66 Medical Research Council trial of prednisone in the nephrotic syndrome.
    Howie AJ; Kizaki T
    Nephrol Dial Transplant; 1993; 8(10):1059-63. PubMed ID: 8272216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.